Bibliography for: "Effect of phorbol myristate acetate (PMA) and ionophore A23187 on interleukin-2 levels and proliferation of activated T lymphocytes from patients with lepromatous leprosy"

Fernando Alfaro-Bustamante "Effect of phorbol myristate acetate (PMA) and ionophore A23187 on interleukin-2 levels and proliferation of activated T lymphocytes from patients with lepromatous leprosy". International Journal of Leprosy and Other Mycobacterial Diseases. FindArticles.com. 22 Dec, 2009. http://findarticles.com/p/articles/mi_qa3754/is_199703/ai_n8736367/

International Journal of Leprosy and Other Mycobacterial Diseases

View more issues:

Articles in Mar 1997 issue of International Journal of Leprosy and Other Mycobacterial Diseases

• Don't Treat Me Like I Have Leprosy! A Guide to Overcoming Prejudice and Segregation
  by Robert C Hastings
• "Umbilicated" lesions in histoid leprosy
  by Ashok K Sharma
• Regarding Pinitsoontorn, et al.'s rapid village survey / Dr. Pinitsoontorn replies
  by Somdej Pinitsoontorn
• A study on the effectiveness and safety of the WHO/MDT regimen in the Northeast of Thailand; a prospective study, 1984-1996
  by Krongkarn Dasananjali; Pieter A M Schreuder; Charoon Pirayavaraporn
• Leprosy in children
  by Pailoor Jayalakshmi; M Tong; Santokh Sing; T. Ganesapillai
• Low serum HDL-cholesterol is associated with raised tumor necrosis factor-alpha during ENL reactions
  by Riaz A Memon; Arnawaz Kifayet; Fidaus Shahid; Anisa Lateef; et al
• Cytokine gene expression in the foot pad and spleen of BALB/cAJcl mice infected with M. leprae
  by Yasuko Yogi; Hiroko Nomaguchi; Yoshiki Sakamoto; Masanori Matsuoka; et al
• Effect of phorbol myristate acetate (PMA) and ionophore A23187 on interleukin-2 levels and proliferation of activated T lymphocytes from patients with lepromatous leprosy
  by Fernando Alfaro-Bustamante; Gabriela Ramirez-Flores; Amado Gonzalez-Mendoza; Alfonso Islas-Rodriguez; Mary Fafutis-Morris
• Influence of DDT exposure on susceptibility to human leprosy bacilli in mice
  by Basu D Banerjee; Bidhan C Koner; Sayed T Pasha
• Immunotherapy of lepromin-negative borderline leprosy patients with low-dose convit vaccine as an adjunct to multidrug therapy; A six-year follow-up study in Calcutta
  by Sachin Chaudhury; Sunil Kumar Hajra; Ashutosh Mukerjee; Bibbuti Saha; et al
• Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients
  by Silvia de la Barrera; Marta Finiasz; Susana Fink; Raul Valdez; et al
• Regarding Ebenezer, et al.'s MB nerve histology in clinically diagnosed BT leprosy patients / Dr Ebenezer replies
  by Richard I Frankel; Gigi J Ebenezer
• Effect of steriod therapy on parameters of peripheral autonomic dysfunction in leprosy patients with acute neuritis
  by Annelies Wilder-Smith; Einar Wilder-Smith
• Daily multidrug therapy for leprosy; results of a fourteen-year experience
  by Georges-Yves de Carsalade; Daniel Wallach; Edith Spindler; Jean Pennec; et al
• Regional lymphadenitis following antileprosy vaccine BCG with killed Mycobacterium leprae
  by R Lourduraj John De Britto; Vadakkupattu D Ramanathan; Mohan D Gupte
• Pathologic changes in a tibial nerve with surviving M. leprae in a healed tuberculoid leprosy patient
  by Charles K Job; Balasubramani Baskaran; Joseph Jayakumar; Maria Aschhoff